KPL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Kwality Pharmaceuticals has informed BSE that its trading window for dealing in company shares will remain closed starting Thursday, January 01, 2026, until 48 hours after the declaration of unaudited financial results for the quarter and nine months ended December 31, 2025. The closure applies to all Board members, Designated Persons, and their immediate relatives, prohibiting any share transactions during this period. This is a standard compliance measure under SEBI's Insider Trading Regulations, 2015, typically undertaken ahead of quarterly results. The exact date of the Board meeting to approve the Q3 FY26 results has not yet been disclosed and will be communicated later.
This is a routine regulatory disclosure with no material impact on the stock. It signals that Q3 FY26 results are likely to be announced in early-to-mid January 2026, which investors should watch for as the next key catalyst for the stock.